Followers | 251 |
Posts | 50194 |
Boards Moderated | 47 |
Alias Born | 08/29/2007 |
Saturday, April 06, 2024 2:14:59 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent TARS News
- Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference • GlobeNewswire Inc. • 05/09/2024 09:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:12:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:09:45 PM
- Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements • GlobeNewswire Inc. • 05/08/2024 08:05:00 PM
- Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 • GlobeNewswire Inc. • 05/01/2024 09:00:00 PM
- Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon • GlobeNewswire Inc. • 04/23/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:57:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:45:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:12:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:10:44 PM
- Tarsus to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:09:18 PM
- Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis • GlobeNewswire Inc. • 03/05/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:26:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/01/2024 10:17:56 PM
- Tarsus Announces Pricing of $100.0 Million Public Offering • GlobeNewswire Inc. • 03/01/2024 05:07:38 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/29/2024 10:08:19 PM
- Tarsus Announces Proposed $100.0 Million Public Offering • GlobeNewswire Inc. • 02/29/2024 09:37:35 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 02/29/2024 09:32:14 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2024 09:22:36 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 09:02:01 PM
- Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements • GlobeNewswire Inc. • 02/27/2024 11:00:00 AM
- Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept “Tick-Kill” Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease • GlobeNewswire Inc. • 02/22/2024 01:00:00 PM
- Tarsus to Report Fourth Quarter and Full Year 2023 Financial Results on Tuesday, February 27, 2024 • GlobeNewswire Inc. • 02/20/2024 10:00:00 PM
- Tarsus to Participate in Fireside Chat at the Sixth Annual Guggenheim Healthcare Talks Conference • GlobeNewswire Inc. • 01/31/2024 10:00:00 PM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM